Intensive chemotherapy is the treatment of choice for elderly patients with acute myelogenous leukemia.

  title={Intensive chemotherapy is the treatment of choice for elderly patients with acute myelogenous leukemia.},
  author={Kenneth A. Foon and Jacob Zighelboim and Charles E. Yale and Robert Peter Gale},
  volume={58 3},
One-hundred and seven patients with acute myelogenous leukemia (AML) ranging in age from 15 to 82 yr who were previously untreated, received a 70 day high-dose remission induction regimen consisting of daunorubicin, cytarabine, and thioguanine (TAD). Identical complete remission rates of 65% were observed for 33 patients 60 yr of age and older and for 74 patients age 15-59 yr. Median remission duration and survival were 14 mo and 22 mo for patients 60 yr and older, and 16 mo and 22 mo for… CONTINUE READING
17 Citations
17 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 17 extracted citations


Publications referenced by this paper.
Showing 1-10 of 17 references

Acute myeloblastic leukemia in elderly patients . Treatment and prognostic factors

  • BA Peterson, CD Bloomfield
  • Cancer
  • 1980

Long chemotherapyfree 263 adult patients with acute nonlymphoblastic leukemia . Blood remissions after singlecycle timedsequential chemotherapy for 56 : 77378 I , I 980 acute myelocytic leukemia

  • P Schaver, A Friedman, +5 authors PJ Burke
  • 1980

FGJ: Treatment of acute myeloid leukaemia with a triple cytotoxic regime, DAT

  • JKH Rees, RM SandIer, J Challenger, Hayhoe
  • Br J Cancer 36:770-776,
  • 1977

High remission-duration rate in acute mycloid leukemia

  • RP Gale, MJ Cline
  • Lancet 1:497-499,
  • 1977

Similar Papers

Loading similar papers…